Morgan Stanley’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.6M | Sell |
391,187
-56,125
| -13% | -$2.67M | ﹤0.01% | 2878 |
|
|
2025
Q4 | $16.7M | Buy |
447,312
+11,270
| +3% | +$458K | ﹤0.01% | 3096 |
|
|
2025
Q3 | $17.6M | Sell |
436,042
-55,779
| -11% | -$1.84M | ﹤0.01% | 2999 |
|
|
2025
Q2 | $12.6M | Buy |
491,821
+13,415
| +3% | +$293K | ﹤0.01% | 3238 |
|
|
2025
Q1 | $10.2M | Sell |
478,406
-10,609
| -2% | -$237K | ﹤0.01% | 3323 |
|
|
2024
Q4 | $10.3M | Sell |
489,015
-41,776
| -8% | -$967K | ﹤0.01% | 3387 |
|
|
2024
Q3 | $12M | Buy |
530,791
+84,964
| +19% | +$1.64M | ﹤0.01% | 3286 |
|
|
2024
Q2 | $7.48M | Sell |
445,827
-37,121
| -8% | -$597K | ﹤0.01% | 3554 |
|
|
2024
Q1 | $6.24M | Sell |
482,948
-293,390
| -38% | -$3.52M | ﹤0.01% | 3738 |
|
|
2023
Q4 | $8.99M | Buy |
776,338
+290,037
| +60% | +$3.27M | ﹤0.01% | 4005 |
|
|
2023
Q3 | $6.21M | Buy |
486,301
+34,881
| +8% | +$495K | ﹤0.01% | 3560 |
|
|
2023
Q2 | $6.18M | Buy |
451,420
+19,864
| +5% | +$285K | ﹤0.01% | 3603 |
|
|
2023
Q1 | $6.61M | Sell |
431,556
-36,082
| -8% | -$551K | ﹤0.01% | 3541 |
|
|
2022
Q4 | $6.27M | Buy |
467,638
+183,420
| +65% | +$2.46M | ﹤0.01% | 3539 |
|
|
2022
Q3 | $3.78M | Buy |
284,218
+43,740
| +18% | +$755K | ﹤0.01% | 3922 |
|
|
2022
Q2 | $4.6M | Buy |
240,478
+126,352
| +111% | +$2.39M | ﹤0.01% | 3841 |
|
|
2022
Q1 | $2.28M | Buy |
114,126
+13,073
| +13% | +$264K | ﹤0.01% | 4413 |
|
|
2021
Q4 | $2.06M | Sell |
101,053
-13,050
| -11% | -$279K | ﹤0.01% | 4563 |
|
|
2021
Q3 | $2.46M | Sell |
114,103
-66,679
| -37% | -$1.61M | ﹤0.01% | 4400 |
|
|
2021
Q2 | $5.22M | Buy |
180,782
+122,489
| +210% | +$3.31M | ﹤0.01% | 3734 |
|
|
2021
Q1 | $1.42M | Sell |
58,293
-76,178
| -57% | -$1.72M | ﹤0.01% | 4505 |
|
|
2020
Q4 | $2.61M | Sell |
134,471
-46,546
| -26% | -$856K | ﹤0.01% | 3920 |
|
|
2020
Q3 | $3.15M | Buy |
181,017
+118,672
| +190% | +$2.53M | ﹤0.01% | 3197 |
|
|
2020
Q2 | $1.64M | Buy |
62,345
+3,367
| +6% | +$83.6K | ﹤0.01% | 3784 |
|
|
2020
Q1 | $1.43M | Sell |
58,978
-487,092
| -89% | -$11.9M | ﹤0.01% | 3656 |
|
|
2019
Q4 | $13.6M | Sell |
546,070
-79,342
| -13% | -$1.84M | ﹤0.01% | 2065 |
|
|
2019
Q3 | $13.3M | Buy |
625,412
+535,571
| +596% | +$14.7M | ﹤0.01% | 1835 |
|
|
2019
Q2 | $2.85M | Sell |
89,841
-136,958
| -60% | -$4.29M | ﹤0.01% | 3478 |
|
|
2019
Q1 | $7.49M | Buy |
226,799
+103,345
| +84% | +$3.22M | ﹤0.01% | 2322 |
|
|
2018
Q4 | $3.97M | Sell |
123,454
-239,418
| -66% | -$9.03M | ﹤0.01% | 3156 |
|
|
2018
Q3 | $15.6M | Buy |
362,872
+171,639
| +90% | +$8.11M | ﹤0.01% | 1919 |
|
|
2018
Q2 | $8.81M | Buy |
191,233
+79,572
| +71% | +$3.52M | ﹤0.01% | 2515 |
|
|
2018
Q1 | $4.43M | Sell |
111,661
-98,835
| -47% | -$3.66M | ﹤0.01% | 3154 |
|
|
2017
Q4 | $7.05M | Buy |
210,496
+20,185
| +11% | +$717K | ﹤0.01% | 2712 |
|
|
2017
Q3 | $7.05M | Buy |
190,311
+32,592
| +21% | +$1.22M | ﹤0.01% | 2616 |
|
|
2017
Q2 | $5.84M | Sell |
157,719
-15,054
| -9% | -$491K | ﹤0.01% | 2695 |
|
|
2017
Q1 | $4.86M | Buy |
172,773
+2,868
| +2% | +$80.9K | ﹤0.01% | 2893 |
|
|
2016
Q4 | $4.98M | Buy |
169,905
+100,351
| +144% | +$2.74M | ﹤0.01% | 2999 |
|
|
2016
Q3 | $1.89M | Sell |
69,554
-28,468
| -29% | -$644K | ﹤0.01% | 3539 |
|
|
2016
Q2 | $1.83M | Buy |
98,022
+77,964
| +389% | +$1.63M | ﹤0.01% | 3498 |
|
|
2016
Q1 | $543K | Sell |
20,058
-119,013
| -86% | -$3.41M | ﹤0.01% | 4386 |
|
|
2015
Q4 | $4.19M | Buy |
139,071
+63,352
| +84% | +$2.03M | ﹤0.01% | 2838 |
|
|
2015
Q3 | $2.39M | Sell |
75,719
-2,496
| -3% | -$91.1K | ﹤0.01% | 3342 |
|
|
2015
Q2 | $3.05M | Sell |
78,215
-118,781
| -60% | -$4.1M | ﹤0.01% | 3233 |
|
|
2015
Q1 | $6.97M | Sell |
196,996
-5,432
| -3% | -$175K | ﹤0.01% | 2422 |
|
|
2014
Q4 | $6.39M | Buy |
202,428
+195,741
| +2,927% | +$5.41M | ﹤0.01% | 2492 |
|
|
2014
Q3 | $150K | Sell |
6,687
-142,838
| -96% | -$2.86M | ﹤0.01% | 5285 |
|
|
2014
Q2 | $3.28M | Buy |
+149,525
| New | +$2.84M | ﹤0.01% | 3062 |
|
Other funds holding PAHC
VCM
VPM
N
Morgan Stanley's PAHC Position: Q1 2026 in Review
Morgan Stanley reduced its Phibro Animal Health (PAHC) stake by 13% in Q1 2026, selling an estimated $2.67M and leaving 391,187 shares worth $21.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2878.
Morgan Stanley first reported a position in PAHC in Q2 2014 and has held it in 48 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Morgan Stanley held 391,187 shares of Phibro Animal Health worth $21.6M as of Q1 2026.
- Morgan Stanley sold 56,125 Phibro Animal Health shares in Q1 2026, an estimated $2.67M.
- Phibro Animal Health made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2878 holding.
- Morgan Stanley first reported a position in Phibro Animal Health in Q2 2014 and has held it in 48 quarters since.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.